Last reviewed · How we verify

NCT04389970: TREO_MS

Time Restricted Eating Outcomes in Multiple Sclerosis

Completed NA Results posted Last updated 27 March 2024
What this trial tests

NA trial testing Time Restricted Feeding in Multiple Sclerosis in 12 participants. Completed in 30 July 2021.

Timeline
1 October 2020
Primary endpoint
30 July 2021
30 July 2021

Quick facts

Lead sponsorUniversity of Alabama at Birmingham
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment12
Start date1 October 2020
Primary completion30 July 2021
Estimated completion30 July 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Alabama at Birmingham

Who can join

Adults 18 to 65, any sex, with Multiple Sclerosis or Diet, Healthy. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Timed 25-foot Walk Speed Primary · Change from baseline to 8 weeks

Change in timed 25-foot walk test speed between baseline and 8 weeks. Speed calculated as ft per second, and change calculated as speed at baseline - speed at 8 weeks. Higher score indicates better outcome. There are no minimum or maximum values, as this is the measure of the time it takes a participant to walk 25 feet. Higher score indicates higher speed, which is preferable.

GroupValue95% CI
Time Restricted Feeding-.3± 1.2
Short Form McGill Pain Questionnaire Secondary · Change from baseline to 8 weeks

15-item questionnaire requiring respondent to rate types of pain as mild, moderate or severe. Scores range from 0-45, with higher pain intensity indicated by higher score. Change calculated as SFMPQ score at basline - SFMPQ score at 8 weeks.

GroupValue95% CI
Time Restricted Feeding-1.9± 5.4
Modified Fatigue Impact Scale Secondary · Change from baseline to 8 weeks

21-item questionnaire with possible score ranging from 0-84. Higher scores indicate higher impact of fatigue on a person's life. Change in MFIS was calculated as MFIS score at baseline - MFIS score at 8 weeks.

GroupValue95% CI
Time Restricted Feeding-1.3± 14.3
Fatigue Severity Scale Secondary · Change from baseline to 8 weeks

9-item questionnaire in respondents rate each statement from strongly disagree to strongly agree. Total scores range from 9- 63, with higher score indicating higher fatigue severity. Change in FSS calculated as FSS at baseline - FSS at 8 weeks.

GroupValue95% CI
Time Restricted Feeding2.3± 16.7
Pittsburgh Sleep Quality Index Secondary · Change from baseline to 8 weeks

19 self-rated items that produce 7 component scores and 1 global score. Only global scores were calculated for this study. Global scores can range from 0-21, with higher scores indicating poorer sleep quality. Change in PSQI calculated as PSQI at baseline - PSQI at 8 weeks.

GroupValue95% CI
Time Restricted Feeding.2± 4.0
Percent Lean Mass Secondary · Change from baseline to 8 weeks

Lean mass as a percent of total body mass, measured by dual energy x-ray absorptiometry (DXA)

GroupValue95% CI
Time Restricted Feeding0± 1.0
9 Hole Peg Test Speed Secondary · Change from baseline to 8 weeks

Higher score indicates better outcome. Speed on 9 hole peg test was measured as pegs per second, and change in speed was calculated as speed at baseline - speed at 8 weeks. There are no minimum or maximum values, as the measure is time that it takes a person to complete the test. Higher score indicates faster speed, which is preferable.

GroupValue95% CI
Time Restricted Feeding.02± .03
Symbol Digit Modalities Test (SDMT) Secondary · Change from baseline to 8 weeks

The score is the number of symbols identified correctly in 90 seconds. Potential scores range from 0-110. Higher score indicate improved outcome. Change in score on the SDMT calculated as SDMT score at baseline- SDMT score at 8 weeks.

GroupValue95% CI
Time Restricted Feeding5.8± 8.3
Percent Fat Mass Secondary · Change from baseline to 8 weeks

Change in fat mass as percentage of total body mass, measured by DXA. Calculated as percent fat mass at baseline- percent fat mass at 8 weeks.

GroupValue95% CI
Time Restricted Feeding0± 1.0

Sponsor's own description

The purpose of this pilot study is to determine the preliminary efficacy, safety, and acceptability of time restricted feeding (TRF) among a sample of 12 adults with Relapsing-Remitting Multiple Sclerosis (RRMS). The specific aims of this study are: 1: To determine preliminary efficacy of TRF for reducing symptom burden, improving inflammatory markers, and reducing cardiometabolic risk among adults with RRMS. 2: To determine the safety and participant acceptability of TRF. Participants will be asked to consume all food during an 8-hour window each day and not eat for the remaining 16 hours. All participants will follow this eating pattern for 8 weeks.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Feasibility and acceptability of time-restricted eating in a group of adults with multiple sclerosis.
    Wingo BC, Rinker JR, Green K, Peterson CM. · · 2022 · cited 17× · PMID 36712417 · DOI 10.3389/fneur.2022.1087126

Verify or expand the search:

Other trials of Time Restricted Feeding

Trials testing the same drug.

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

Other University of Alabama at Birmingham trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04389970.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing